Analyst Consensus ?
ConsensusHold43 ratings
Bullish2251.2%
Neutral2046.5%
Bearish12.3%
Builders FirstSource, Inc. · BLDR · FY2026 Q1 · Calendar Q2 2026
BLDR Q1 2026: Revenue Beats but EPS Misses 31%, Guidance Cut on Housing Weakness
Builders FirstSource delivered a mixed Q1 2026: revenue topped consensus by 3.6% but EPS fell short by 31%, reflecting gross margin compression in specialty products and inflationary cost pressures on fuel and commodities. Management lowered full-year guidance, citing continued housing market weakness and affordability constraints, while projecting a stronger second half. The stock's abnormal decline of 6.1% on the report, followed by an additional 3.6% downside drift, signals investor concern about the margin trajectory despite management's confident tone, continued share repurchases, and progress on cost-reduction and digital initiatives. With shares at $66.44 versus an analyst consensus target of $90.54, the market is pricing in a materially weaker near-term outlook than the Street's longer-term view.
Reported Before market openNYSEBasic Materials
$7.10B market cap
90quality score
Company context
Snapshot as of publicationBuilders FirstSource, Inc. engages in the supply and manufacture of building materials, manufactured components, and construction services to professional homebuilders, sub-contractors, remodelers, and consumers. Its products include factory-built roof and floor trusses, wall panels and stairs, vinyl windows, custom millwork and trim, and engineered wood. The company was founded by Kevin P. O'Meara, Donald F. McAleenan and John D. Roach in March 1998 and is headquartered in Irving, TX.
Earnings scorecard
Reported versus consensus
Reported EPS
$0.27
Consensus $0
EPS surprise
-30.8%
Reported versus consensus
Reported revenue
$3.29B
Consensus $3.17B
Revenue surprise
+3.6%
Reported versus consensus
Earnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$66.44Current
$65Low
$128.69Average
$230High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Jul 31, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| BMO Capital | Market Perform | Market Perform | Maintain | Jul 28, 2026 |
| Stifel | Hold | Hold | Maintain | Jul 23, 2026 |
| Oppenheimer | Outperform | Outperform | Maintain | Jul 23, 2026 |
| Benchmark | Buy | Buy | Maintain | Jul 23, 2026 |
| Keybanc | Overweight | Overweight | Maintain | Jul 13, 2026 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | May 1, 2026 |
| UBS | Buy | Buy | Maintain | May 1, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | May 1, 2026 |
| DA Davidson | Neutral | Neutral | Maintain | May 1, 2026 |
| Barclays | Overweight | Overweight | Maintain | May 1, 2026 |
| Stephens & Co. | Equal Weight | Equal Weight | Maintain | Apr 27, 2026 |
| B of A Securities | Neutral | Neutral | Maintain | Apr 20, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Apr 13, 2026 |
| Baird | Neutral | Neutral | Maintain | Feb 18, 2026 |
| Jefferies | Hold | Buy | Downgrade | Dec 15, 2025 |
| Zelman & Assoc | Neutral | Underperform | Upgrade | Oct 31, 2025 |
| Wedbush | Neutral | Outperform | Downgrade | Sep 15, 2025 |
| Raymond James | Outperform | Outperform | Maintain | May 2, 2025 |
| Loop Capital | Buy | Buy | Maintain | Apr 14, 2025 |
| Truist Securities | Buy | Buy | Maintain | Feb 21, 2025 |
| Cantor Fitzgerald | Neutral | Overweight | Downgrade | Feb 21, 2025 |
| B. Riley Securities | Buy | Buy | Maintain | Aug 7, 2024 |
| Deutsche Bank | Buy | Buy | Maintain | Jul 12, 2023 |
| BTIG | Neutral | Buy | Downgrade | Aug 2, 2022 |
| Zelman | Sell | Sell | Maintain | Jul 8, 2021 |
| B. Riley FBR | Buy | Neutral | Upgrade | Aug 3, 2020 |
| Evercore ISI Group | In Line | Outperform | Downgrade | Jun 5, 2020 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | Apr 16, 2020 |
| Buckingham Research | Neutral | Neutral | Maintain | Aug 7, 2019 |
| Buckingham | Neutral | Neutral | Maintain | Feb 25, 2019 |
| Stifel Nicolaus | Buy | Buy | Maintain | Aug 9, 2018 |
| MKM Partners | Neutral | Neutral | Maintain | Jun 28, 2018 |
| Citigroup | Neutral | Neutral | Maintain | Nov 10, 2017 |
| B. Riley | Buy | Buy | Maintain | Nov 10, 2017 |
| Seaport Global | Buy | Buy | Maintain | Nov 22, 2016 |
| FBR Capital | Outperform | Outperform | Maintain | Jun 1, 2016 |
| Credit Suisse | Neutral | Neutral | Maintain | Oct 8, 2015 |
| William Blair | Market Perform | Outperform | Downgrade | May 6, 2015 |
| Sterne Agee | Buy | Neutral | Upgrade | Apr 15, 2015 |
| Gabelli & Co. | Buy | Hold | Upgrade | Apr 28, 2014 |
| Imperial Capital | In Line | Outperform | Downgrade | Feb 24, 2014 |
| Williams Capital | Buy | Buy | Maintain | Sep 28, 2012 |
| Sidoti & Co. | Buy | Buy | Maintain | Aug 20, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $66.44. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Oppenheimer | Analyst unavailable | $110 | $70.01 | +65.6% | Jul 23, 2026 |
| D.A. Davidson | Analyst unavailable | $100 | $69.38 | +50.5% | Jul 23, 2026 |
| Stifel Nicolaus | Andrew Carter | $70 | $71.03 | +5.4% | Jul 23, 2026 |
| KeyBanc | Analyst unavailable | $91 | $75.69 | +37.0% | Jul 13, 2026 |
| BMO Capital | Analyst unavailable | $93 | $75.58 | +40.0% | May 5, 2026 |
| Deutsche Bank | Analyst unavailable | $81 | $75 | +21.9% | May 4, 2026 |
| Robert W. Baird | David Manthey | $95 | $79.27 | +43.0% | May 1, 2026 |
| Truist Financial | Analyst unavailable | $115 | $78.97 | +73.1% | May 1, 2026 |
| Oppenheimer | Analyst unavailable | $121 | $79.29 | +82.1% | May 1, 2026 |
| KeyBanc | Jeffrey Hammond | $100 | $79.09 | +50.5% | May 1, 2026 |
| Raymond James | Analyst unavailable | $100 | $79.09 | +50.5% | May 1, 2026 |
| Barclays | Analyst unavailable | $93 | $79.09 | +40.0% | May 1, 2026 |
| Stephens | Analyst unavailable | $100 | $90.05 | +50.5% | Apr 27, 2026 |
| Robert W. Baird | David Manthey | $125 | $114.63 | +88.1% | Feb 18, 2026 |
| Wells Fargo | Sam Reid | $120 | $128.42 | +80.6% | Feb 11, 2026 |
| D.A. Davidson | Analyst unavailable | $111 | $113.92 | +67.1% | Feb 2, 2026 |
| Stephens | Analyst unavailable | $137 | $126.79 | +106.2% | Jan 20, 2026 |
| Barclays | Analyst unavailable | $136 | $126.38 | +104.7% | Jan 15, 2026 |
| RBC Capital | Mike Dahl | $111 | $111.29 | +67.1% | Jan 9, 2026 |
| UBS | Analyst unavailable | $143 | $108.22 | +115.2% | Jan 6, 2026 |
| Jefferies | Analyst unavailable | $110 | $108.46 | +65.6% | Dec 15, 2025 |
| Barclays | Analyst unavailable | $123 | $110.01 | +85.1% | Dec 8, 2025 |
| D.A. Davidson | Analyst unavailable | $115 | $113.69 | +73.1% | Nov 3, 2025 |
| UBS | Analyst unavailable | $166 | $111.69 | +149.8% | Oct 31, 2025 |
| Robert W. Baird | Analyst unavailable | $135 | $113.38 | +103.2% | Oct 31, 2025 |
| Barclays | Analyst unavailable | $124 | $111.69 | +86.6% | Oct 31, 2025 |
| Vertical Research | Analyst unavailable | $109.41 | $122.54 | +64.7% | Oct 20, 2025 |
| KeyBanc | Analyst unavailable | $145 | $121.25 | +118.2% | Oct 1, 2025 |
| Wedbush | Jay McCanless | $145 | $140.17 | +118.2% | Sep 15, 2025 |
| D.A. Davidson | Kurt Yinger | $125 | $128.18 | +88.1% | Aug 4, 2025 |
| Oppenheimer | Tyler Batory | $155 | $135.12 | +133.3% | Jul 10, 2025 |
| BMO Capital | Ketan Mamtora | $135 | $111.86 | +103.2% | May 5, 2025 |
| Robert W. Baird | David Manthey | $130 | $114.13 | +95.7% | May 2, 2025 |
| B.Riley Financial | Alex Rygiel | $220 | $181.47 | +231.1% | Nov 6, 2024 |
| D.A. Davidson | Steven Chercover | $175 | $181.47 | +163.4% | Nov 6, 2024 |
| Barclays | Matthew Bouley | $211 | $196.73 | +217.6% | Oct 9, 2024 |
| Loop Capital Markets | Jeffrey Stevenson | $230 | $201.83 | +246.2% | Sep 20, 2024 |
| Oppenheimer | Tyler Batory | $225 | $195.02 | +238.7% | Sep 18, 2024 |
| Truist Financial | Keuth Hughes | $220 | $183.3 | +231.1% | Sep 16, 2024 |
| Loop Capital Markets | Jeffrey Stevenson | $190 | $155.73 | +186.0% | Aug 7, 2024 |
| Robert W. Baird | David Manthey | $190 | $155.73 | +186.0% | Aug 7, 2024 |
| Oppenheimer | Tyler Batory | $230 | $167.49 | +246.2% | Jul 29, 2024 |
| RBC Capital | Mike Dahl | $206 | $149.97 | +210.1% | Jun 6, 2024 |
| Robert W. Baird | David Manthey | $185 | $162.69 | +178.4% | May 29, 2024 |
| Stifel Nicolaus | Stanley Elliott | $217 | $162.62 | +226.6% | May 7, 2024 |
| Barclays | Matthew Bouley | $240 | $202.77 | +261.2% | Apr 4, 2024 |
| Deutsche Bank | Analyst unavailable | $90 | $69.16 | +35.5% | Jan 11, 2023 |
| Robert W. Baird | David Manthey | $100 | $69.88 | +50.5% | Aug 16, 2022 |
| Truist Financial | Analyst unavailable | $85 | $72.11 | +27.9% | Aug 2, 2022 |
| Truist Financial | Keith Hughes | $90 | $60.42 | +35.5% | Apr 27, 2022 |
| Benchmark Co. | Reuben Garner | $125 | $76.48 | +88.1% | Dec 8, 2021 |
| Wedbush | Jay McCanless | $85 | $65.4 | +27.9% | Nov 4, 2021 |
| Stephens | Trey Grooms | $65 | $49.7 | -2.2% | Aug 17, 2021 |
| Stifel Nicolaus | Stanley Elliott | $69 | $47.29 | +3.9% | Aug 6, 2021 |
Track every rating change on BLDR the moment it posts. Free to start.
Start freeMarket reaction
prior-close to event-session close
Stock move
-5.1%
Event window
SPY move
+1.0%
Same window
Abnormal move
-6.1%
Stock minus SPY
Volume
2.9×
Versus trailing sessions
Subsequent drift
-3.6%
Up to 20 sessions
BLDRSPY benchmark
Follow BLDR with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeTranscript intelligence
What changed
Q1 revenue of $3.29B beat the $3.17B estimate by 3.6%, but EPS of $0.27 missed the $0.39 consensus by 31%. Gross margin contracted to 28.3% due to specialty product headwinds and higher fuel and inflation costs. The company realized $6M of its targeted $100M in annual productivity savings. Management revised full-year guidance lower, now expecting sales of $14.6–15.6B and adjusted EBITDA of $1.1–1.5B, while still projecting a stronger second half. The board authorized an additional $500M in share repurchases, with $303M executed in Q1 despite leverage near the upper end of the target range.
Guidance delta
Full-year guidance was lowered. Revenue range revised to $14.6–15.6B and adjusted EBITDA to $1.1–1.5B, down from prior expectations. Management projects a stronger second half driven by spring selling season benefits and cost-reduction initiatives. Capex outlook remains stable.
Key takeaways
- Q1 sales fell 10% year-over-year to $3.3B, but management claimed market share gains through value-added solutions
- Revenue beat consensus by 3.6% while EPS missed by 31%, reflecting gross margin compression to 28.3% from specialty product headwinds and inflationary costs
- Cost-reduction program targets $100M in annual savings; $6M realized in Q1, on track for $50–70M of productivity savings
- Strong liquidity of $1.5B and ongoing share repurchases ($303M in Q1) despite net debt-to-EBITDA near 3.2x, the upper end of the target range
- Board authorized an additional $500M share repurchase, signaling management confidence even amid higher leverage
Management priorities
- Launch next-generation digital platform with four integrated hubs later this year
- Continue SAP implementation with broader rollout anticipated in 2027
- Achieve $50–70M of full-year productivity savings as part of $100M cost-reduction target
- Pursue strategic acquisitions to expand value-added product offerings
- Maintain disciplined capital allocation including ongoing share repurchases
- Expand digital quoting platform and AI-enabled tools for share-gain initiatives
Related earnings events
Basic MaterialsSources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
- Polygon adjusted daily market bars · 2026-07-31T20:51:22.089995+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-07-31T20:51:22.086603+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated . For educational purposes only; not investment advice.